Pivot Path appoints Mukta Arora as Independent Director EP News Bureau Sep 8, 2026 She has held senior leadership roles at Eli Lilly, Elanco and Astellas Pharma, where she has focused on building and scaling…
How Pivot Path is in a sweet spot to address pharma’s pressure points Viveka Roychowdhury Sep 7, 2026 Pivot Path emerged from Strides Pharma's internal GCC. Are other pharma companies also following the same playbook? And if so,…
Strides partners with Ascent Capital to unlock value in Pivot Path EP News Bureau Jun 29, 2026 Deal values Pivot Path at ~₹2.3 billion post-money; Strides to realise ~₹1 billion while retaining around 20 per cent stake.
